NRx Pharmaceuticals, Inc.
NASDAQ:NRXPBiotechnology
Healthcare
$2.55 +1.43%
+$0.06 today
- Market cap
- $113.04M
- Beta
- 2.19
- P/E (TTM)
- -5.3
- EPS (TTM)
- -$0.76
52W Low $1.62High $5.06
Volume 1.39M
Average 1.27M
Balance Sheet
Inspect the capital base behind the business.
Assets
$12.96M
FY 2025 · Annual
+254.9% YoYLiabilities
$28.89M
FY 2025 · Annual
+7.5% YoYEquity
-$15.94M
FY 2025 · Annual
Balance Sheet
USD
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $6.7M |
| Receivables | $181.0K |
| Other Current | $467.0K |
| Total Current Assets | $7.4M |
| PP&E (Net) | $936.0K |
| Goodwill | $1.8M |
| Intangible Assets | $879.0K |
| Long-term Investments | $399.0K |
| Other Non-current | $535.0K |
| Total Non-current Assets | $4.5M |
| Total Assets | $11.9M |
Analysis
Selected assets total $11.9M for Latest. The largest visible component is Cash & Equivalents at $6.7M, about 56.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| DEF 14A | DEF 14A filing | Nov 5, 2026 | |
| DEFA14A | DEFA14A filing | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 4, 2026 | |
| 8-K | Current report | Nov 2, 2026 |
How much cash does NRXP have?
NRx Pharmaceuticals, Inc. (NRXP) reported $7.80M in cash and equivalents in fiscal 2025.
How much debt does NRXP carry?
NRx Pharmaceuticals, Inc. (NRXP) reported $631,000.00 of total debt, with net debt of -$7.17M.
Continue the stock analysis
Jump to another research area for this company.